These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 30113617)

  • 1. Omics and bioinformatics applied to vaccine development against Borrelia.
    Bencurova E; Gupta SK; Oskoueian E; Bhide M; Dandekar T
    Mol Omics; 2018 Oct; 14(5):330-340. PubMed ID: 30113617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Borrelia burgdorferi Surface-Exposed Transmembrane Protein Lacking Detectable Immune Responses Supports Pathogen Persistence and Constitutes a Vaccine Target.
    Kung F; Kaur S; Smith AA; Yang X; Wilder CN; Sharma K; Buyuktanir O; Pal U
    J Infect Dis; 2016 Jun; 213(11):1786-95. PubMed ID: 26747708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR; Telford SR; Hu LT
    Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
    Eschner AK; Mugnai K
    Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eliminating Factor H-Binding Activity of
    Marcinkiewicz AL; Lieknina I; Kotelovica S; Yang X; Kraiczy P; Pal U; Lin YP; Tars K
    Front Immunol; 2018; 9():181. PubMed ID: 29472926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach to a Lyme disease vaccine.
    Livey I; O'Rourke M; Traweger A; Savidis-Dacho H; Crowe BA; Barrett PN; Yang X; Dunn JJ; Luft BJ
    Clin Infect Dis; 2011 Feb; 52 Suppl 3():s266-70. PubMed ID: 21217174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches toward the directed design of a vaccine against Borrelia burgdorferi.
    Luft BJ; Dunn JJ; Lawson CL
    J Infect Dis; 2002 Feb; 185 Suppl 1():S46-51. PubMed ID: 11865439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borrelia burgdorferi BBI39 Paralogs, Targets of Protective Immunity, Reduce Pathogen Persistence Either in Hosts or in the Vector.
    Singh P; Verma D; Backstedt BT; Kaur S; Kumar M; Smith AA; Sharma K; Yang X; Azevedo JF; Gomes-Solecki M; Buyuktanir O; Pal U
    J Infect Dis; 2017 Mar; 215(6):1000-1009. PubMed ID: 28453837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Borrelia burgdorferi outer surface proteins.
    Brooks CS; Vuppala SR; Jett AM; Akins DR
    Infect Immun; 2006 Jan; 74(1):296-304. PubMed ID: 16368984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
    Grosenbaugh DA; Rissi DR; Krimer PM
    Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula.
    Nassal M; Skamel C; Kratz PA; Wallich R; Stehle T; Simon MM
    Eur J Immunol; 2005 Feb; 35(2):655-65. PubMed ID: 15668917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responses.
    Guarino C; Asbie S; Rohde J; Glaser A; Wagner B
    Vaccine; 2017 Jul; 35(33):4140-4147. PubMed ID: 28668566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.
    O'Connor TP; Esty KJ; Hanscom JL; Shields P; Philipp MT
    Clin Diagn Lab Immunol; 2004 May; 11(3):458-62. PubMed ID: 15138170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lyme disease vaccine takes its toll.
    Thomas V; Fikrig E
    Vector Borne Zoonotic Dis; 2002; 2(4):217-22. PubMed ID: 12804162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development.
    Oliver LD; Earnhart CG; Virginia-Rhodes D; Theisen M; Marconi RT
    Vet J; 2016 Dec; 218():27-33. PubMed ID: 27938705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and development of a novel vaccine for protection against Lyme borreliosis.
    Comstedt P; Hanner M; Schüler W; Meinke A; Lundberg U
    PLoS One; 2014; 9(11):e113294. PubMed ID: 25409015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Borrelia burgdorferi BbHtrA Protease as a Vaccine Candidate for Lyme Borreliosis in Mice.
    Ullmann AJ; Russell TM; Dolan MC; Williams M; Hojgaard A; Weiner ZP; Johnson BJ
    PLoS One; 2015; 10(6):e0128868. PubMed ID: 26076465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines.
    Nassal M; Skamel C; Vogel M; Kratz PA; Stehle T; Wallich R; Simon MM
    Int J Med Microbiol; 2008 Jan; 298(1-2):135-42. PubMed ID: 17888729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Need for a New Lyme Disease Vaccine.
    Plotkin SA
    N Engl J Med; 2016 Sep; 375(10):911-3. PubMed ID: 27602662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.